“Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours”. (2022) Journal of Medical Sciences, 17(1), pp. 1–7. doi:10.51984/joms.v17i1.1892.